TNNI3 and COVID-19: Previous reports about COVID-19 showed a significant increase in cardiac lesion biomarkers, including Cardiac troponin I (cTnI), Creatine Kinase (CK), α-hydroxybutyrate dehydrogenase (HBDB), Lactate Dehydrogenase (LDH), and NT-proBNP [14–17] (Table 1).